using sbrt to delay systemic therapy for patients with oligometastatic rcc
Published 1 year ago • 128 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:18
using radiotherapy to manage oligometastatic kidney cancer
-
2:41
stereotactic body radiotherapy and concomitant systemic therapy for oligoprogressive breast cancer
-
0:48
combining radiotherapy and io for patients with oligometastatic rcc
-
2:49
recent advances in radiotherapy for oligometastatic disease
-
2:21
first-line treatment decision making for patients with rcc
-
1:10
optimizing treatment for renal cell carcinoma with sequential therapies
-
9:59
evidence for local treatment of oligometastatic disease
-
1:39
the impact of time-to-treatment on sbrt outcomes
-
4:02
stereotactic body radiotherapy (sbrt) in nsclc
-
51:07
rcc sbrt/srs 2.0 session 12: treatment of sbrt (pt. 2) | sastry vedam
-
3:04
evaluating the role of radiotherapy in primary and metastatic rcc
-
0:35
the latest developments in adjuvant therapy for rcc
-
9:40
new trends in sbrt for kidney cancer
-
2:50
the role of cytoreductive nephrectomy and metastasectomy in renal cell carcinoma
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
45:30
liver stereotactic body radiotherapy (sbrt): primary and oligometastatic by joseph herman, md
-
9:57
oligometastatic renal cell carcinoma
-
1:14:16
rcc sbrt/srs 2.0 session 10: hypofractionation clinical applications | dr. robert timmerman
-
2:40
updates on the cabopre phase ii trial in patients with metastatic renal cell carcinoma